BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37595583)

  • 21. Understanding Arrhythmogenic Cardiomyopathy: Advances through the Use of Human Pluripotent Stem Cell Models.
    Chua CJ; Morrissette-McAlmon J; Tung L; Boheler KR
    Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium as a Key Player in Arrhythmogenic Cardiomyopathy: Adhesion Disorder or Intracellular Alteration?
    Moccia F; Lodola F; Stadiotti I; Pilato CA; Bellin M; Carugo S; Pompilio G; Sommariva E; Maione AS
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31426283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.
    Amin G; Castañeda SL; Zabalegui F; Belli C; Atorrasagasti C; Miriuka SG; Moro LN
    Stem Cell Res; 2023 Sep; 71():103157. PubMed ID: 37393721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Label-free conduction velocity mapping and gap junction assessment of functional iPSC-Cardiomyocyte monolayers.
    Dou W; Zhao Q; Malhi M; Liu X; Zhang Z; Wang L; Masse S; Nanthakumar K; Hamilton R; Maynes JT; Sun Y
    Biosens Bioelectron; 2020 Nov; 167():112468. PubMed ID: 32829174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.
    Meraviglia V; Arendzen CH; Tok M; Freund C; Maione AS; Sommariva E; Bellin M
    Stem Cell Res; 2020 Jul; 46():101835. PubMed ID: 32485643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knock Down of Plakophillin 2 Dysregulates Adhesion Pathway through Upregulation of miR200b and Alters the Mechanical Properties in Cardiac Cells.
    Puzzi L; Borin D; Gurha P; Lombardi R; Martinelli V; Weiss M; Andolfi L; Lazzarino M; Mestroni L; Marian AJ; Sbaizero O
    Cells; 2019 Dec; 8(12):. PubMed ID: 31847412
    [No Abstract]   [Full Text] [Related]  

  • 27. Plakophilin-2 Haploinsufficiency Causes Calcium Handling Deficits and Modulates the Cardiac Response Towards Stress.
    van Opbergen CJM; Noorman M; Pfenniger A; Copier JS; Vermij SH; Li Z; van der Nagel R; Zhang M; de Bakker JMT; Glass AM; Mohler PJ; Taffet SM; Vos MA; van Rijen HVM; Delmar M; van Veen TAB
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31438494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineered Heart Slice Model of Arrhythmogenic Cardiomyopathy Using Plakophilin-2 Mutant Myocytes.
    Blazeski A; Lowenthal J; Wang Y; Teuben R; Zhu R; Gerecht S; Tomaselli G; Tung L
    Tissue Eng Part A; 2019 May; 25(9-10):725-735. PubMed ID: 30520705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MYH10 activation rescues contractile defects in arrhythmogenic cardiomyopathy (ACM).
    García-Quintáns N; Sacristán S; Márquez-López C; Sánchez-Ramos C; Martinez-de-Benito F; Siniscalco D; González-Guerra A; Camafeita E; Roche-Molina M; Lytvyn M; Morera D; Guillen MI; Sanguino MA; Sanz-Rosa D; Martín-Pérez D; Garcia R; Bernal JA
    Nat Commun; 2023 Oct; 14(1):6461. PubMed ID: 37833253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plakophilin 2 couples actomyosin remodeling to desmosomal plaque assembly via RhoA.
    Godsel LM; Dubash AD; Bass-Zubek AE; Amargo EV; Klessner JL; Hobbs RP; Chen X; Green KJ
    Mol Biol Cell; 2010 Aug; 21(16):2844-59. PubMed ID: 20554761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The genetic architecture of Plakophilin 2 cardiomyopathy.
    Dries AM; Kirillova A; Reuter CM; Garcia J; Zouk H; Hawley M; Murray B; Tichnell C; Pilichou K; Protonotarios A; Medeiros-Domingo A; Kelly MA; Baras A; Ingles J; Semsarian C; Bauce B; Celeghin R; Basso C; Jongbloed JDH; Nussbaum RL; Funke B; Cerrone M; Mestroni L; Taylor MRG; Sinagra G; Merlo M; Saguner AM; Elliott PM; Syrris P; van Tintelen JP; ; James CA; Haggerty CM; Parikh VN
    Genet Med; 2021 Oct; 23(10):1961-1968. PubMed ID: 34120153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).
    Yang J; Samal E; Burgos Angulo M; Bertalovitz A; McDonald TV
    Stem Cell Res; 2021 Jul; 54():102398. PubMed ID: 34034221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular disturbance underlies to arrhythmogenic cardiomyopathy induced by transgene content, age and exercise in a truncated PKP2 mouse model.
    Moncayo-Arlandi J; Guasch E; Sanz-de la Garza M; Casado M; Garcia NA; Mont L; Sitges M; Knöll R; Buyandelger B; Campuzano O; Diez-Juan A; Brugada R
    Hum Mol Genet; 2016 Sep; 25(17):3676-3688. PubMed ID: 27412010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of iPSC line from patient with arrhythmogenic right ventricular cardiomyopathy carrying mutations in PKP2 gene.
    Khudiakov A; Kostina D; Zlotina A; Yany N; Sergushichev A; Pervunina T; Tomilin A; Kostareva A; Malashicheva A
    Stem Cell Res; 2017 Oct; 24():85-88. PubMed ID: 29034900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arrhythmogenic right ventricular cardiomyopathy mutations alter shear response without changes in cell-cell adhesion.
    Hariharan V; Asimaki A; Michaelson JE; Plovie E; MacRae CA; Saffitz JE; Huang H
    Cardiovasc Res; 2014 Nov; 104(2):280-9. PubMed ID: 25253076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants of electrical propagation and propagation block in Arrhythmogenic Cardiomyopathy.
    Jin Q; Lee KY; Selimi Z; Shimura D; Wang E; Zimmerman JF; Shaw RM; Kucera JP; Parker KK; Saffitz JE; Kleber AG
    J Mol Cell Cardiol; 2024 Jan; 186():71-80. PubMed ID: 37956903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [THE EFFECT OF PLAKOPHILIN-2 GENE MUTATIONS ON ACTIVITY OF THE CANONICAL Wnt SIGNALING PATHWAY].
    Khudiakov AA; Kostina DA; Kostareva AA; Tomilin AN; Malashicheva AB
    Tsitologiia; 2015; 57(12):868-75. PubMed ID: 26995964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modeling incomplete penetrance in arrhythmogenic cardiomyopathy by human induced pluripotent stem cell derived cardiomyocytes.
    De Bortoli M; Meraviglia V; Mackova K; Frommelt LS; König E; Rainer J; Volani C; Benzoni P; Schlittler M; Cattelan G; Motta BM; Volpato C; Rauhe W; Barbuti A; Zacchigna S; Pramstaller PP; Rossini A
    Comput Struct Biotechnol J; 2023; 21():1759-1773. PubMed ID: 36915380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.
    Chen Y; Zeng D; Ding L; Li XL; Liu XT; Li WJ; Wei T; Yan S; Xie JH; Wei L; Zheng QS
    BMC Cell Biol; 2015 Sep; 16():22. PubMed ID: 26335746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-specific iPSC-derived cardiomyocytes reveal aberrant activation of Wnt/β-catenin signaling in SCN5A-related Brugada syndrome.
    Cai D; Wang X; Sun Y; Fan H; Zhou J; Yang Z; Qiu H; Wang J; Su J; Gong T; Jiang C; Liang P
    Stem Cell Res Ther; 2023 Sep; 14(1):241. PubMed ID: 37679791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.